Source:http://linkedlifedata.com/resource/pubmed/id/16918569
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2006-8-21
|
pubmed:abstractText |
Facial lipoatrophy has been observed to occur in a variety of patient populations, with inherited or acquired disease, or even in aging patients as a natural progression of tissue change over time. There is currently no framework from which physicians of all medical specialties can communally discuss the manifestations, diagnoses, and management of facial lipoatrophy.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1076-0512
|
pubmed:author |
pubmed-author:AlsterTinaT,
pubmed-author:AscherBenjaminB,
pubmed-author:BauerUteU,
pubmed-author:BurgessCherylC,
pubmed-author:ButterwickKimberlyK,
pubmed-author:ColemanSydneyS,
pubmed-author:DonofrioLisaL,
pubmed-author:EngelhardPeterP,
pubmed-author:GoldmanMitchel PMP,
pubmed-author:KatzPhilippeP,
pubmed-author:VleggaarDannyD
|
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1058-69
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading | |
pubmed:year |
2006
|
pubmed:articleTitle |
Full scope of effect of facial lipoatrophy: a framework of disease understanding.
|
pubmed:affiliation |
Clinique Iena, Paris, France. benjaminascher@wanadoo.fr
|
pubmed:publicationType |
Journal Article,
Consensus Development Conference
|